Cited by 40Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesNeuroscience and Neuropharmacology Research

Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder

Maccioni, Paola, Colombo, Giancarlo·2019·CNS Drugs

Abstract

The orthosteric γ-aminobutyric acid B (GABA B) receptor agonist baclofen is currently considered a therapeutic option for alcohol use disorder (AUD); however, the safety profile of baclofen is a concern, thus arousing interest in the positive allosteric modulators (PAMs) of the GABA B receptor (GABA B PAMs), a new class of ligands expected to possess a better safety profile. The present paper summarizes the several lines of experimental evidence indicating the ability of GABA B PAMs to inhibit multiple alcohol-motivated behaviors in rodents. All GABA B PAMs tested to date have invariably been reported to reduce, or even suppress, excessive alcohol drinking, relapse- and binge-like drinking, operant oral alcohol self-administration, reinstatement of alcohol seeking, and alcohol-induced locomotor stimulation and conditioned place preference in rats and mice. The use of validated animal models of several aspects of AUD confers translational value to these findings. The reducing effects of GABA B PAMs on alcohol-motivated behaviors (1) occurred at doses largely lower than those inducing sedation, suggesting that GABA B PAMs may possess, if compared with baclofen, a higher therapeutic index and a more favorable safety profile, and (2) were often not associated with reductions on other non-drug consummatory behaviors. Additional findings with therapeutic potential were (1) the lack of tolerance, after repeated treatment, to the reducing effect of GABA B PAMs on alcohol drinking and self-administration; (2) the efficacy of GABA B PAMs after intragastric administration; and (3) the ability of GABA B PAMs to selectively potentiate the suppressing effect of baclofen on alcohol self-administration. The recent transition of the first GABA B PAMs to the initial steps of clinical testing makes investigation of the efficacy of GABA B PAMs in AUD patients a feasible option.

Integrity signals

Registry

Crossref · 10.1007/s40263-018-0596-3

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ASP8062 is a novel agent that acts as a positive allosteric modulator of GABA-B, similar to baclofen, which is an orthosteric GABA-B receptor agonist.

    “ASP8062 is a novel agent which acts as a positive allosteric modulator of GABA-B, similar to baclofen, which is an orthosteric GABA-B receptor agonist [58].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maccioni, P., & Colombo, G.
Affiliations
National Research Council (IT)
Corresponding author
Maccioni, Paola
Venue
CNS Drugs
Published
2019-01-02
Volume
33
Issue
2
Pages
107-123
ISSN
  • 1172-7047 (ISSN-L)
  • 1179-1934
OpenAlex
W2907707759
Cited by
40
References
69
Citations by year
2026: 2 · 2025: 1 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 5 · 2019: 2
FWCI
2.75
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • CNR ExploRA (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
GABAB receptors, positive allosteric modulators, alcoholism, baclofen, alcohol self-administration, alcohol relapse, binge drinking, conditioned place preference, tolerance (pharmacology and immunology), therapeutic index, drug safety, animal models of alcoholism
MeSH terms
Allosteric Regulation, Animals, Conditioning, Psychological, Humans, Motor Activity, Reinforcement, Psychology, Molecular Structure, Receptors, GABA-B, Alcohol-Related Disorders, GABA-B Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review